Association between MTHFR C677T, MTHFR A1298C and MS A2756G polymorphisms and risk of cervical intraepithelial neoplasia II/III and cervical cancer: A meta-analysis

Zhu,Jie; Wu,Lei; Kohlmeier,Martin; Ye,Fangli; Cai,Wei

doi:10.3892/mmr.2013.1589

Association between MTHFR C677T, MTHFR A1298C and MS A2756G polymorphisms and risk of cervical intraepithelial neoplasia II/III and cervical cancer: A meta-analysis

Authors:
- Jie Zhu
- Lei Wu
- Martin Kohlmeier
- Fangli Ye
- Wei Cai
View Affiliations

Affiliations: Xin Hua Hospital, Shanghai Institute for Pediatric Research, School of Medicine, Shanghai Jiaotong University, Shanghai 200092, P.R. China, Medical College, Wuhan University of Science and Technology, Wuhan, Hubei 430065, P.R. China, Nutrigenetics Laboratory, UNC Nutrition Research Institute, University of North Carolina at Chapel Hill, Kannapolis, NC 28081, USA
Published online on: July 16, 2013 https://doi.org/10.3892/mmr.2013.1589
Pages: 919-927

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Numerous case-control studies on the association between polymorphisms of key genes involved in methionine remethylation [methylenetetrahydrofolate reductase (MTHFR) and methionine synthase (MS)] and the susceptibility of cervical intraepithelial neoplasia (CIN) and cervical cancer have provided inconclusive results. The aim of the present meta-analysis was to determine the effects of two MTHFR (C677T and A1298C) and one MS gene polymorphism (A2756G) on the risk of CIN II/III or cervical cancer. Relevant data were retrieved following a systematic search in PubMed, Web of Science, MEDLINE and Wanfang Data up to November 2012. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were estimated from eligible studies by meta-analysis with subgroup analyses stratified by ethnicity. A total of 13 studies with 1,936 cases and 2,858 controls were included in the present meta‑analysis. An increased risk of cervical cancer was found in Asian women with the MTHFR 677T allele (TT vs. CC: OR=1.41, 95% CI=1.07‑1.86, P=0.01; TT vs. CC+CT: OR=1.38, 95% CI=1.08-1.75, P=0.008), while a decreased risk was observed in Caucasian women (TT vs. CC: OR=0.65, 95% CI=0.45-0.93, P=0.02; TT+CT vs. CC: OR=0.7, 95% CI=0.58-0.86, P=0.0005). No effects of MTHFR C677T polymorphism on CIN II/III risk and MTHFR A1298C or MS A2756G polymorphisms on cervical cancer risk were detected. The sensitivity analysis suggested stability of this meta-analysis and no publication bias was detected. The MTHFR 677T allele may enhance the risk of cervical cancer in the Asian female population and play a protective role in Caucasian females. However, limited association is suggested between MTHFR A1298C and MS A2756G polymorphisms with cervical tumorigenesis.

View Figures

View References

1	Piyathilake CJ, Macaluso M, Johanning GL, Whiteside M, Heimburger DC and Giuliano A: Methylenetetrahydrofolate reductase (MTHFR) polymorphism increases the risk of cervical intraepithelial neoplasia. Anticancer Res. 20:1751–1757. 2000.PubMed/NCBI
2	Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar
3	Kohaar I, Kumar J, Thakur N, et al: Homocysteine levels are associated with cervical cancer independent of methylene tetrahydrofolate reductase gene (MTHFR) polymorphisms in Indian population. Biomarkers. 15:61–68. 2010. View Article : Google Scholar
4	Kohaar I, Thakur N, Salhan S, et al: TNFα-308G/A polymorphism as a risk factor for HPV-associated cervical cancer in Indian population. Cell Oncol. 29:249–256. 2007.
5	García-Closas R, Castellsagué X, Bosch X and González CA: The role of diet and nutrition in cervical carcinogenesis: a review of recent evidence. Int J Cancer. 117:629–637. 2005.PubMed/NCBI
6	Tong SY, Kim MK, Lee JK, et al: Common polymorphisms in methylenetetrahydrofolate reductase gene are associated with risks of cervical intraepithelial neoplasia and cervical cancer in women with low serum folate and vitamin B12. Cancer Causes Control. 22:63–72. 2011. View Article : Google Scholar
7	Kjellberg L, Hallmans G, Ahren AM, et al: Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection. Br J Cancer. 82:1332–1338. 2000.PubMed/NCBI
8	Josefsson AM, Magnusson PK, Ylitalo N, et al: Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet. 355:2189–2193. 2000. View Article : Google Scholar : PubMed/NCBI
9	Gerhard DS, Nguyen LT, Zhang ZY, Borecki IB, Coleman BI and Rader JS: A relationship between methylenetetrahydrofolate reductase variants and the development of invasive cervical cancer. Gynecol Oncol. 90:560–565. 2003. View Article : Google Scholar
10	Yamada K, Chen Z, Rozen R and Matthews RG: Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductase. Proc Natl Acad Sci USA. 98:14853–14858. 2001. View Article : Google Scholar : PubMed/NCBI
11	Tong SY, Lee JM, Song ES, et al: The effects of polymorphisms in methylenetetrahydrofolate reductase (MTHFR), methionine synthase (MTR), and methionine synthase reductase (MTRR) on the risk of cervical intraepithelial neoplasia and cervical cancer in Korean women. Cancer Causes Control. 21:23–30. 2010. View Article : Google Scholar
12	Prasad VV and Wilkhoo H: Association of the functional polymorphism C677T in the methylenetetrahydrofolate reductase gene with colorectal, thyroid, breast, ovarian, and cervical cancers. Onkologie. 34:422–426. 2011. View Article : Google Scholar : PubMed/NCBI
13	Goodman MT, McDuffie K, Hernandez B, et al: Association of methylenetetrahydrofolate reductase polymorphism C677T and dietary folate with the risk of cervical dysplasia. Cancer Epidemiol Biomarkers Prev. 10:1275–1280. 2001.PubMed/NCBI
14	Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005. View Article : Google Scholar
15	Kang S, Kim JW, Kang GH, Park NH, Song YS, Kang SB and Lee HP: Polymorphism in folate- and methionine-metabolizing enzyme and aberrant CpG island hypermethylation in uterine cervical cancer. Gynecol Oncol. 96:173–180. 2005. View Article : Google Scholar : PubMed/NCBI
16	Powers HJ: Interaction among folate, riboflavin, genotype, and cancer, with reference to colorectal and cervical cancer. J Nutr. 135(Suppl 12): S2960–S2966. 2005.PubMed/NCBI
17	Zoodsma M, Nolte IM, Schipper M, et al: Methylenetetrahydrofolate reductase (MTHFR) and susceptibility for (pre)neoplastic cervical disease. Hum Genet. 116:247–254. 2005. View Article : Google Scholar : PubMed/NCBI
18	Hazra A, Wu K, Kraft P, Fuchs CS, Giovannucci EL and Hunter DJ: Twenty-four non-synonymous polymorphisms in the one-carbon metabolic pathway and risk of colorectal adenoma in the Nurses’ Health Study. Carcinogenesis. 28:1510–1519. 2007.PubMed/NCBI
19	Stroup DF, Berlin JA, Morton SC, et al: Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 283:2008–2012. 2000. View Article : Google Scholar
20	Qi X, Ma X, Yang X, et al: Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls. Breast Cancer Res Treat. 123:499–506. 2010. View Article : Google Scholar : PubMed/NCBI
21	Sull JW, Jee SH, Yi S, et al: The effect of methylenetetrahydrofolate reductase polymorphism C677T on cervical cancer in Korean women. Gynecol Oncol. 95:557–563. 2004. View Article : Google Scholar : PubMed/NCBI
22	Shekari M, Sobti RC, Kordi Tamandani DM, et al: Impact of methylenetetrahydrofolate reductase (MTHFR) codon (677) and methionine synthase (MS) codon (2756) on risk of cervical carcinogenesis in North Indian population. Arch Gynecol Obstet. 278:517–524. 2008. View Article : Google Scholar
23	Mostowska A, Myka M, Lianeri M, Roszak A and Jagodziński PP: Folate and choline metabolism gene variants and development of uterine cervical carcinoma. Clin Biochem. 44:596–600. 2011. View Article : Google Scholar : PubMed/NCBI
24	Lambropoulos AF, Agorastos T, Foka ZJ, Chrisafi S, Constantinidis TC, Bontis J and Kotsis A: Methylenetetrahydrofolate reductase polymorphism C677T is not associated to the risk of cervical dysplasia. Cancer Lett. 191:187–191. 2003. View Article : Google Scholar : PubMed/NCBI
25	Delgado-Enciso I, Martínez-Garza SG, Rojas-Martínez A, et al: The effect of MTHFR polymorphisms, pregnancy and first intercourse on cervical cancer in a population from the Northeastern Mexico. Rev Invest Clin. 58:462–469. 2006.(In Spanish).
26	Piyathilake CJ, Azrad M, Macaluso M, Johanning GL, Cornwell PE, Partridge EE and Heimburger DC: Protective association of MTHFR polymorphism on cervical intraepithelial neoplasia is modified by riboflavin status. Nutrition. 23:229–235. 2007. View Article : Google Scholar : PubMed/NCBI
27	Wang JT, Ma XC, Cheng YY, Ding L and Zhou Q: A case-control study on the association between folate and cervical cancer. Zhonghua Liu Xing Bing Xue Za Zhi. 27:424–427. 2006.(In Chinese).
28	Agodi A, Barchitta M, Cipresso R, et al: Distribution of p53, GST, and MTHFR polymorphisms and risk of cervical intraepithelial lesions in sicily. Int J Gynecol Cancer. 20:141–146. 2010. View Article : Google Scholar : PubMed/NCBI
29	Muñoz N, Bosch FX, de Sanjosé S, et al; International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 348:518–527. 2003.
30	Hemminki K, Dong C and Vaittinen P: Familial risks in cervical cancer: is there a hereditary component? Int J Cancer. 82:775–781. 1999. View Article : Google Scholar : PubMed/NCBI
31	Blount BC, Mack MM, Wehr CM, et al: Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci USA. 94:3290–3295. 1997. View Article : Google Scholar : PubMed/NCBI
32	Esteller M and Herman JG: Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J Pathol. 196:1–7. 2002. View Article : Google Scholar : PubMed/NCBI
33	Fowler BM, Giuliano AR, Piyathilake C, Nour M and Hatch K: Hypomethylation in cervical tissue: is there a correlation with folate status? Cancer Epidemiol Biomarkers Prev. 7:901–906. 1998.PubMed/NCBI
34	Weisberg I, Tran P, Christensen B, Sibani S and Rozen R: A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab. 64:169–172. 1998. View Article : Google Scholar : PubMed/NCBI
35	Rao GG, Kurien A, Gossett D, Griffith WF, Coleman RL and Muller CY: A case-control study of methylenetetrahydrofolate reductase polymorphisms in cervical carcinogenesis. Gynecol Oncol. 101:250–254. 2006. View Article : Google Scholar : PubMed/NCBI
36	Hubner RA and Houlston RS: MTHFR C677T and colorectal cancer risk: a meta-analysis of 25 populations. Int J Cancer. 120:1027–1035. 2007. View Article : Google Scholar : PubMed/NCBI
37	Chen J, Giovannucci E, Kelsey K, et al: A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res. 56:4862–4864. 1996.PubMed/NCBI
38	Hankey GJ and Eikelboom JW: Homocysteine and stroke. Lancet. 365:194–196. 2005. View Article : Google Scholar : PubMed/NCBI
39	Magnusson PK, Sparén P and Gyllensten UB: Genetic link to cervical tumours. Nature. 400:29–30. 1999. View Article : Google Scholar : PubMed/NCBI